The cardiotoxidty of streptolysin O was first demonstrated by Bemheimer and Cantoni (1) who induced systolic contracture in the frog heart perfused with the toxin. Subsequently, Kellner et al. (2) showed that permanent and irreversible standstill, accompanied by a profound but transitory reduction in coronary flow, resulted from the exposure of the isolated hearts of guinea pigs, rabbits, and rats to small amounts of the toxin. Halpem and Rahman (3) found that the electrocardiograms of mice given large lethal doses of toxin exhibited immediate and intense bradycardia followed, in some cases, by temporary arrest; progressive atrioventricular dissociation implicated the conductile tissue. Electrocardiograms, obtained by Halbert, Bircher, and Dahle (4) from rabbits given lethal and sublethal doses of highly purified streptolysin O, were characterized by conduction defects and ventricular automatism. Intravenous injection of several multiples of the Ires0 was followed within 3-4 sec by a rapid transition from normal sinus rhythm to ventricular arrhythmia, ventricular fibrillation, and standstill. Frequently, smaller lethal doses and sublethal doses immediately produced a pronounced but transient sinus bradycardia, followed by temporary or permanent recovery. The transient nature of this bradycardia, along with the extremely rapid effects of the toxin in vivo, suggested that its toxicity might result from the release of vasoactive substances rather than from the direct action of the protein itself. Accordingly, Halbert et al. (5) studied the effectiveness of various pharmacological blocking agents in protecting against the putative physiologically active agent(s) responsible for the intravenous effects of streptolysin O. Although the several agents which exhibited protection were serotonin antagonists, there was little correlation between this property and protection. In addition, serotonin was not very toxic to rabbits and mice, so it appeared unlikely that the acute toxicity of streptolysin O could be accounted for entirely by the release of this amine.
In subsequent studies, Halbert et al. (6) considered the likelihood that the in vivo cardiovascular changes observed were consequent to an elevated plasma potassium concentration resulting from intravascular hemolysis. They found sufficient discrepancies, however, in the relationships among hemolysis, potassium levels, and electrocardiographic changes to render inadequate this mechanism as being responsible for the rapid lethality of the toxin. Furthermore, the pharmacologic agent most protective against this lethality had no effect against hemolysis or the toxicity of KC1.
The present work (see also reference 7) endeavors to extend the in vitro studies (1, 2) and to investigate the provocative in vivo electrocardiographic findings (3) (4) (5) (6) by an analysis of the electrophysiological, pharmacological, and mechanical changes occurring in the isolated whole heart and separate cardiac tissues of the guinea pig pursuant to their challenge with streptolysin O.
Materials and Methods
Toxin.--Highly purified preparations of streptolysin O, obtained from Group A and Group C streptococcal extracellular concentrates, were supplied as lyoph~l~zed powders in the oxidized state. ~ These preparations were made according to methods previously described (8) (9) (10) (11) (12) and had been used in other studies (4) (5) (6) . The Group A toxin consisted entirely of protein and had a titer of 160,000 hemolytic units (HU) per milligram of dry weight; the Group C material, which was 67% protein, had a tlter of 40,000 HU/mg.
In experiments on guinea pig cardiac tissues, the Group A and Group C preparations behaved identically, producing comparable physiological effects when present in the same hemolytic potencies. In both cases, the magnitudes of these effects correlated closely with the hemolytic activities.
Toxin stock solutions were prepared daily by dissolving the lyophilized powder in 0.15 ~* sodium phosphate buffer of pH 7.3. The toxin was activated by reduction with 10 mg/ml L-cysteine-HCl. The reduction reaction was allowed to proceed for 10 min at 30°C, after which the activated stock solution was placed in an ice bath. The direct effect of cysteine on the whole heart and isolated atria, a slight depression of rate and amplitude, was largely eliminated by diluting the stock toxin solutions at least 1 : 10 with buffer before testing them on the tissue.
Antiloxin.--Normal pooled human gamma globulin (E. R. Squibb & Sons, New York), a 16% solution containing known streptococcal antibodies with an anti-streptolysin O titer of 2000 Todd anti-streptolysin units/ml (8) (9) (10) (11) , was furnished through the American Red Cross. Two purified plasma proteins, human serum albumin (Cutter Laboratories, Berkeley, Calif.), and bovine gamma globulin (Armour & Co., Chicago, Ill.), were used for control of antitoxin.
add butanolamide bimaleate (UML-491); 4 (f) serotonin creatinine sulfate; ~ and (g) n-acetyl serotonin. ~ N~dri~nt Media for Isolated Tissues.--Studies involving the isolated cardiac tissues of guinea pigs, rabbits, and rats were carried out in Chenoweth's solution (14) ; the bioassays on the guinea pig ileum, in Tyrode's solution. Both media were prepared daily from reagents of analytical grade in water redistUled over alkaline permanganate. Chenoweth's solution was continuously equilibrated with 95% O~-5% CO2 to give a pH of 7.4; Tyrode's solution, pH 7.8, was gassed with 100% O~.
Experimental Anima/s.--Normal male guinea pigs, ranging in weight from 250-500 g, were used in these studies.
Preparation of Tissue.--Cardiac tissues were prepared according to a common general procedure (15) (16) (17) . Each animal was primed with an intraperitoneal dose (5 mg/kg) of sodium heparin and killed 10 min later by a blow to the base of the skull. After cannulation of the ascending aorta, the heart was excised, connected to the standpipe of an Anderson perfusiou apparatus,6 and perfused at 37°C. Such hearts were either left in place or removed and appropriately dissected for experiments on the separate cardiac tissues.
In studies of the mechanical and electrical responses of isolated atrial pairs, the atria were dissected as a single tissue from the ventricles. Individual left or right atria were prepared from atrial pairs surgically separated so that the sinoatrial node remained intact in the tight atrium. Isolated ventricle strips were obtained from hearts treated as described above and prepared as described by Feigen et al. (18) .
Procedurea ar~t Apparatus.--Intact whole hearts were perfused through the coronaries on the Anderson apparatus. The perfusion rate was measured by collecting the perfusate in graduated tubes at 30 see intervals. Contractions were recorded on an Offner Dynograph, Type 506, by means of a transducer attached through a thread to the apex of the ventricles. Toxin and pharmacological agents were added to the standpipe above the heart and flushed through the tissue with normal Chenoweth's; atropine or eserine, dissolved in Chenoweth's, was continuously perfused through the heart.
Simultaneous recordings of the electrophysiological and mechanical activity of atrial and ventricular tissues were made using equipment and methods adequately described previously (15, 16) . Intracellular potentials, measured with standard glass microelectrodes, and mechanical activity, monitored by a moveable-anode transducer, were displayed on a twin beam oscilloscope and photographed by an oscilloscope camera. Atrial preparations were stimulated with a biphasic 1.0 msec pulse, 10 v above threshold, at a rate approximately 10 beats/rain above the natural rate. Ventricle strips were similarly driven at a rate of 180 beats/min.
The mechanical activity of isolated, spontaneously beating atria was studied on tissues mounted vertically in water-jacketed muscle baths having a volume of 3.5 ml. The recording system consisted of a Statham G-TA transducer, G-18 control box, and the Offner Dynograph. Temperature was maintained at 30 4-0.5°C; at this temperature the rate was 53%, of that at 37°C, and the contraction amplitude 210% of that at 37°C; preparations were stable for at least 20 hr.
The bioassays for acetylcholine were made on strips of guinea pig's ileum prepared and standardized according to the usual techniques employed in this laboratory (19, 20) . Each strip was secured to a glass rod and mounted in a 3.5 ml, water-jacketed muscle bath maintalned at 37°C.
RESULTS
The Action of Stmptolysin 0 on the Whole Heart.--The addition of a small dose (36 HU) of active toxin to the solution perfusing an isolated guinea pig heart resulted in a gradual, monotonic decrease in the amplitude of contraction (Fig.  1 A) . As the dose of streptolysin O was increased, the character of this response was altered by the appearance of a rapid, but transient, decrease in the rate and amplitude, superimposed on the gradual decline ( Fig. 1 B-1 D) . Larger doses produced an immediate, reversible cardiac arrest (characterized by both atrial and ventricular standstill) followed by partial recovery of the rate and ampli- tude before the long-term effect became dominant (Fig. 1 D) . This biphasic nature of the response is illustrated graphically in Fig. 2 , which describes the responses of three hearts to different doses of toxin.
These mechanical changes were accompanied by marked alterations in the rate of cardiac perfusion (2) . Doses of streptolysin O greater than about 120 units produced an immediate and permanent cessation of flow. Hearts subjected to such levels of toxin always stopped beating completely within 6-15 rain after challenge. In these cases, it was not possible to separate the consequences of the direct action of the toxin on the contraction processes, from the deleterious effects of the decreased perfusion. These effects are shown by the dashed curve of Fig. 2 , which represents the decrease in amplitude subsequent to clamp-ing off the flow of perfusion fluid to a normal heart. The resulting decline in force of contraction closely parallels that seen with the higher doses of toxin.
Lower levels of streptolysin O induced a rapid, but transient, decrease in perfusion rate. In these cases, the flow gradually recovered to an extent inversely dependent upon the dose of toxin, and the hearts did not stop beating but continued to contract indefinitely at a small fraction of their control amplitude (see Fig. 1 A and B) . Although flow sometimes returned to as much as 95 % of the control level, the amplitude of contraction never recovered to more than about 15 % of its prechallenge level.
.oFI In hearts reacting to large doses of toxin, the depression, or even the complete cessation, of activity during the initial phase was common to both atria and ventricles. Similarly, the partial spontaneous recovery of rate and amplitude was shared by both tissues. At the height of the recovery, however, the ventricles began to lose contractile force. They became partially, and then completely, dissociated from sinoatrial rhythm and began to beat irregularly. The atria, on the other hand, continued to recover and, at ventricular standstill, still beat strongly. If such intoxicated hearts were then dissected and the atria and ventricles separately tested, it was found that the atria would beat spontaneously and vigorously at their control rates for many hours and that electrically driven ventricle strips were indistinguishable in their performance from strips obtained from normal hearts.
These preliminary observations suggested that the localization of the physiological disturbance and the analysis of the mode of action of the toxin might be facilitated by first studying the behavior of the individual cardiac tissues rather than the whole organ.
The Action of Streptolysin 0 on the Isolated Atria.--Mechanical properties: The characteristic response of the spontaneously beating atria to activated streptolysin O consisted of a lag period followed by a transient decrease in rate and amplitude of contraction (Fig. 3) . The lag period, the time between administration of the test dose and the onset of the response, was inversely dependent upon the toxin concentration. When plotted semilog- arithmically, the lag period decreased linearly at a rate of 11 sec per 10-fold increase in toxin dose (e.g.: 26 sec at 100 HU/ml, 15 sec at 1000 HU/ml).
Dose-response functions of the transient changes in atrial rate and amplitude were sigmoidal. These functions showed that the toxin exerted a much more profound depression on the force of contraction than on the frequency: a dose of 25 HU/ml, which produced a 50% reduction in force, depressed the rate by only 3 %.
The spontaneous recovery of the atria from the depressant effects of the toxin was characterized by a transient potentiation in rate and amplitude above control values. Washing out the bath after challenge accelerated the recovery and exaggerated the potentiation.
Qualitative tests on rabbit and rat atria showed that these tissues exhibited the same characteristic response to the toxin.
The repeated challenge of guinea pig atria with a constant dose of streptolysin O produced a gradual decline in responsiveness. This tachyphylaxis is exhibited in the tracings of Fig. 4 taken from an atrial preparation subjected four times to challenge with 115 HU/ml. Each successive challenge was characterized by a prolongation of the lag peroid and a reduction in the depth of response. The rate of decline of responsiveness was dose dependent, and semilogo arithmic plots of these functions were linear. The first order velocity constants (K), derived from these plots, are presented in Table I . Table I I shows that there was no recovery of responsiveness with time. A single atrial preparation, challenged six times with 158 H U / m l of streptolysin O, was then maintained for 250 min in frequently renewed medium before the seventh challenge. In spite of this considerable delay, the response to the seventh challenge was still less than that observed for the sixth challenge.
Electrical properties: The electrophysiological consequence of exposing driven atria to streptolysin O was to increase the rate of repolarization of the action potential. Fig. 5 presents oscillographic records of the intracellular potential and mechanical contraction before (trace A), and 45 sec after (trace B), challenge with 140 HU/ml of reduced toxin; quantitatively, treatment of an atrial preparation with 720 HU/ml of active toxin for 45 sec increased the initial slope of the repolarization phase of the potential from the control rate of 0.73 v/sec to 2.4 v/sec without measurably affecting the depolarization phase. In these studies, the mechanical and electrical changes began within 20-60 sec following the addition of the toxin; but, whereas the action potential returned to its control configuration in 2-3 rain, the contraction did not fully recover until 8-12 rain after challenge. Additional electrophysiological studies made on separated atria showed that there was no difference between the right and left atria with respect to their electrical or mechanical reactions to streptolysin O.
Evidence for Release of Acetylchobine by Toxin-Treated Atria.--From a careful
analysis of electrocardiographic records (those cited in references 3 and 4) as FIo. 6 . The recorded responses of isolated atria to five concentrations of acetylchollne at 37°C. The e~ect of w~h~ng out (W) the bath on the rate of recovery.
well as from the transiently decreased frequency, amplitude of contraction, and increased rate of repolarization observed in the present experiments, there was sufficient circumstantial evidence to suggest that the reversible phase of streptolysin cardiotoxicity was due to the release of acetylcholine. In order to test this idea, it had to be shown by quantitative experiments that both acetylcholine and streptolysin O, given in comparably effective doses, produced identical electrical and mechanical changes; that both effects could be blocked by atropine and potentiated by eserine; and, finally, that the release of acetylcholine from atria challenged with streptolysin 0 could be demonstrated unequivocally.
Comparison of the effects of acetylcholine and streptolysin 0 on the isolated atria:
The responses of isolated atrial preparations to five concentrations of acetylcholine are shown in the recordings of Fig. 6 . They consist of a dose-dependent decrease in rate and amplitude of contraction followed by spontaneous recovery characterized by a transient potentiation. This pattern of response is identical with that observed in tissues challenged with streptolysin O (see Fig. 3 ). However, unlike streptolysin O which depressed the amplitude of contraction less with each repeated challenge, the reaction to iterated doses of acetylcholine was one of slight potentiation.
Electrophysiologically, the treatment of electrically driven atria with acetylcholine resulted in a dose-dependent increase in the rate of repolarization of the intracellular potential as seen in Fig. 7 B. These effects are quite similar to those produced by streptolysin O (see Fig. 5 ).
Effects of pharmacological agents:
If the release of acetylcholine is a significant component of the atrial response to the toxin, the reaction to streptolysin O ought to be blocked by atropine and potentiated by eserine. The ability of atropine to block the electrophysiologicM manifestations of streptolysin O action on the isolated atria is demonstrated in Fig. 7 . The presence of atropine, in a concentration sufficient to eliminate the striking increase in the rate of repolarizafion produced by 2.5 X 10 -z ~ acetylcholine (Fig. 7 B) , completely blocked the effects of streptolysin O on the repolarization rate (Fig. 7 D , compare with Fig. 5 B) .
The actions of atropine and eserine on the mechanical changes produced by streptolysin O are shown in Fig. 8 . The slight depression of amplitude caused by 30 HU/ml of toxin (atria A) turned into a profound and prolonged depression of amplitude and frequency when this test dose of toxin was given to an atrial preparation surviving in the presence of 6.9 X 10 -7 M eserine (atria B). On the other hand, the effects of a trebled concentration of toxin were seen to be blocked completely in the presence of 8.2 X 10 -7 ~ atropine (atria C).
Detection and estimation of acetylckoline released from atria exposed to streptolysin O: Although circumstantial, the foregoing evidence was entirely consistent with the hypothesis that the toxin preparations released acetylcholine from atrial tissues. However, initial attempts to demonstrate de facto release from single, or even multiple (three) atrial preparations by assaying the bath or perfusion fluids were unsuccessful, presumably because of (a) the presence of powerful tissue acetylcholinesterases, and (b) the high degree of dilution to which any net release inevitably was subjected.
A test of the potency of atrial acetylcholinesterases was made by determining the rate of inactivation of exogenous acetylcholine. Four atria were assembled into a bundle and immersed in 10 ml of gassed Chenoweth's solution containing 10.8 X 10 -4 #moles of acetylcholine chloride. The reaction was allowed to proceed at 37°C for 12 min during which 0.1 ml samples were drawn at the times Table I I I . The concentrations of residual acetylcholine at these times were obtained by bioassay on the guinea pig's ileum. The results given in Table I I I show a linear reduction in concentration over the first 12 mln. When these data were corrected for the dry weight of the tissue Fla. 8. The response of an isolated atrial preparation to 30 HU/ml of streptolysin O (atria A). Modification by eserine of the response of another atrial pair challenged simultaneously with the same toxin concentration (atria B), and by atropine of the response of a third preparation to a threefold increase in toxin dose (atria C). A dose of 89 HU/ml of active toxin produced no effect when first incubated with cholesterol (atria D). Heating the toxin first (56°C, l0 rain) also destroyed its depressant effects (atria E). (30°C.) (98.5 rag) the initial rate of destruction at 37°C was found to be 3.4 X 10 -4 /zmoles acetylcholine/g dry atrium/min.
From these results, it was clear that measurable amounts of acetylcholine could be obtained only if a large quantity of atrial tissue were challenged in the presence of eserine, and if samples of reaction fluid were taken at a very early stage in the reaction. As further steps, very high concentrations of toxin were used and the reaction temperature was lowered from 37°C to 25°C.
Accordingly, 10 pairs of atria were assembled into a bundle and immersed into a 6.0 X 10 -v ~ solution of eserine made up in Chenoweth's medium. After an equilibration period of 3 min the tissue was transfrered to a flask containing streptolysin O (838 HU/ml) in eserinized Chenoweth's. At the same time, for control purposes, an appropriate quantity of toxin was added to the original equilibration flask to bring the toxin concentration to the same strength as that present in the challenge solution. After 3 min of reaction, the tissue was removed and its dry weight determined. The solutions from both flasks were transferred into 15 ml centrifuge cones, heated to 56°C for 10 rain to inactivate the toxin, chilled, centrifuged at 5°C for 15 min, and then bioassayed for acetylcholine on the guinea pig's ileum, (Fig. 9 A) . Activity was present in both the control and the challenge fluids, suggesting that a certain amount of spontaneously released material had accumulated in the eserinized medium. Challenge with toxin clearly increased the concentration of this material, since the addition of 0.6 ml of the challenge solution produced a contraction that was 2.5 times greater than that given by an equal volume of the control. In the presence of 7.5 X 10 ~5 ~ atropine, the response to both the test and control solutions was blocked, whereas the tissue was still responsive to histamine under these conditions.
In a second release experiment, 12 atrial pairs were challenged with twice the concentration of toxin used earlier, but for half the time. The bioassay record (Fig. 9 B) permits the construction of a standardization curve to acetylcholine and thus the calculation of the concentrations (acetylcholine equivalents) of the active atropine-sensitive material liberated. On this basis, it was computed that the control solution contained 9.8 X 10 -4 #moles of spontaneously released acetylcholine, and that the challenge solution contained 18.8 X 10 --4 #moles as acetylcholine equivalents. Thus, the net release due to the action of streptolysin O was 9.0 × 10-4/~moles. Correcting this value by the dry weight of the tissue (247 mg), and for the reaction period (90 sec), the unit rate of release was 2.5 X 10 -3 gmoles acetylcholine/g of dry atrium/min.
The remained to demonstrate the effects of the toxin on the isolated ventricular myocardium.
As mentioned earlier, electrically driven ventricle strips, obtained from streptolysin-intoxicated hearts in ventricular arrest, appeared to function normally. Similarly, the exposure of ventricle strips obtained from normal, untreated hearts to high concentrations of active toxin (up to 400 HU/ml) established that streptolysin O had no detectable effect on the rate and amplitude of contraction nor upon the configuration of the intracellular potential (Fig. 10 A) . In addition, this preparation was completely insensitive to acetylcholine; concentrations in excess of 1.4 X 10 -~ ~ failed to have any effect on the recorded parameters (Fig. 10 A) .
The Significance of Acelylcholine Release to the Cardiotoxidty of Streptolysin
O.--Having demonstrated that acetylchofine could be released from atria by streptolysin 0 and that the liberation of this transmitter substantially accounted for the functional changes observed in this tissue, we thought it appropriate to consider the contribution of this phenomenon to the toxicity of streptolysin O in the intact organ. Fig. 11 compares the effects of two concentrations of streptolysin O with their functionally equivalent doses of acetylcholine. There is a striking similarity between the transient depression of rate and amplitude resulting from acetylcholine administration and the initial phase of the toxin effect. The difference between the actions of the two agents lies in the recovery phase. The recovery of the acetylcholine-treated hearts was complete, whereas the toxin-treated organs recovered only partially, and then declined irreversibly.
The effects of atropine and eserine on the response of the whole heart to streptolysin O are demonstrated in Fig. 12 . The initial rate of decrease of amplitude produced by 132 units of active toxin was accelerated in the presence of 6.9 X 10 -7 ~ eserine, whereas atropine (1.4 X 10-e ~) blocked this initial phase even when the streptolysin O dose was doubled. Although these agents greatly influenced the course of the response in its initial stages, they had no effect on the rate of the irreversible decline of the terminal phase as evidenced by the convergence of the three curves of Fig. 12 at about 4 mln. In addition, these agents had no measurable influence over the changes in perfusion flow rate produced by challenge with the toxin. Very high concentrations of serotonin creatinlne sulfate (2.0 X 10 -4 M) applied to the peffused heart produced a slight, fully reversible decrease in rate and amplitude of contraction, accompanied by a marked increase in the perfusion rate (up to 100%). The serotonln-blocking agent, UML-491, modified this response but had no effect on any part of the response of the whole heart to 240 units of streptolysin O. Electrically driven atria responded only to very high concentrations of either • serotonin creatinine sulfate or n-acetyl serotonin. For example, a concentration of 4.7 X 10-6 M of the n-acetyl derivative produced a rapid, 110% increase in amplitude which continued until renewal of the medium. Even such high concentrations failed to produce any measurable alterations in the intracellular potential. UML-491 (1.25 X 10 -3 mg/ml) protected the preparation against these serotonin doses but did not alter its response to 240 HU/ml of streptolysin O.
Similarly, large doses of these compounds increa~eA the amplitude of contraction of the electrically driven ventricle strip, but had no effect on the configuration of the action potential. Fig. 10 B shows the results of exposing such a preparation to 1 X 10 -7 ~¢ serotonin for 120 sec and 10 min; the marked potentiation of the contraction is not accompanied by observable electrical ahanges.
Evidence that the Cardiotoxic Factor is Streptolysin O.--Although the streptolysin O preparations used were highly purified, they were known to be contamlnated with small amounts of one or two other antigens (4, 10) . Certain properties of streptolysin O were used to ensure that the effects considered in this report were owed to the action of that molecule (1, 2, 4) and not to possible impurities.
Inactivity of the oxidized state: In tests on the whole heart and isolated atria, reversibly oxidized Group A and Group C toxins--having potential hemolytic potencies of up to 1200 HU/ml--produced none of the changes in rate and amplitude of contraction which characterized the actions of the same concentration of the reduced material. Similarly, bubbling oxygen through active streptolysin O reduced the potency of the toxin to a degree dependent upon the extent of oxygenation.
Inhibition by cholesterol: Aliquots of the activated toxin were incubated with the cholesterol suspension and then tested on the isolated atria. Fig. 8 D shows that such a treatment completely inhibited the effects of 89 HU/ml of the toxin preparation. Incubation of atria with cholesterol suspension, followed by thorough washing, failed to protect the tissues from subsequent challenge with active streptolysin O.
Heat inactivation: The thermolability of our toxin preparations was demonstrated by heating the toxin-buffer solutions (56°C for 10 rain) prior to activation with cysteine. In the example of Fig. 8 E, heat-treated toxin produced no response when added to the bath (final concentration 115 HU/ml).
Neutralization by specific antibody: Pooled normal human T-globulin at a concentration of 160 mg/ml was used in these studies. An aliquot of 0.5 ml of Group C toxin, activated with cysteine and diluted to give a final concentration of 5880 HU/ml, was incubated at 24°C for 5 min with 0.25 ml of the human q,-globulin. The data in Table IV demonstrate that the severe depression of atrial contraction produced by three doses of untreated toxin was completely prevented by preincubating the toxin with antibody. Controls, in which streptolysin 0 was similarly incubated with human sermn albumin or bovine 3'-globulin before being tested on the atria, showed that these proteins provided no protection against the effects of the toxin. 
DISCUSSION
These studies, performed with rather highly purified toxin preparations, confirm the in vitro findings of Kellner et al. (2) who demonstrated the ability of microgram quantities of reduced streptolysin 0 to induce cardiac standstill in isolated mammalian hearts. In addition, however, it has been shown that the response of the whole heart to this toxin consists of two separate and distinct phases. There is initially a rapid, but transient, decrease in the rate and amplitude of contraction associated with the release of acetylcholine from the atria. These events are superimposed on the second phase, a gradual, irreversible decline in ventricular contraction.
The initial phase appears to be entirely atrial in origin and exactly parallels the action of the toxin on the isolated atria. Both the whole heart and the atria show an immediate, dose-dependent reduction in rate and amplitude of con-traction followed by spontaneous recovery. This is complete in the isolated atria, but in the whole organ it is interrupted by the gradual and irreversible decline in ventricular function. The transient depression can be accounted for by the toxin-induced release of acetylcholine since (a) there is excellent correspondence between the actions of streptolysin O and acetylcholine on the whole heart and on the isolated atria; (b) the increase in the rate of repolarization of the atrial action potential caused by streptolysin O is characteristic of the action of acetylcholine; (c) atropine modified the initial phase of the reaction of the whole heart to streptolysin O and completely protected the isolated atria from its effects; (d) eserine aggravated the transient depression in the whole heart and isolated atria; and, finally, (e) acetylcholine was pharmacologically identified in the solutions bathing multiple atria challenged with streptolysin O.
The initial difficulties in recovering this acetylcholine can be understood after consideration of the kinetics of its release and destruction. Endogenous transmitter is released in dose proximity to the cholinergic receptors so that small amounts produce rapid and profound changes. This action is necessarily transient in nature, however, because of rapid enzymatic hydrolysis. Any acetylcholine which escapes destruction encounters barriers to diffusion from its site of release to the bulk phase medium, so that only a small percentage can be recovered from the solution surrounding the tissue.
These problems were overcome by using large quantities of tissue, high doses of toxin, and by blocking the enzymatic destruction of acetylcholine with eserine. We were thus able to detect, biologically, a net release of 2.5 X 10 -~ #moles acetylcholine/g of dry tissue/rain from atria challenged with toxin. The rate of destruction of exogenous acetylcholine, estimated from the data of Table HI, amounts to 3.4 X 10 -~ #moles acetylcholine/g of dry atrium/rain. Although these quantities and rates are gross approximations of the actual acetylcholine release and destruction at the cellular level, they provide evidence of the formidable barriers to quantitative recovery.
The observed atrial tachyphylaxis to repeated doses of streptolysin O could have come about because of an interference with the tissue receptors for acetylcholine, or because of a defect in the apparatus concerned with either the metabolism or release of the compound. Although prellmiuary experiments on this question indicate that there is no alteration in the tissue receptor for acetylcholine, these studies were not sufficiently critical, and we are not yet able to distinguish with certainty among these possible defects.
The terminal phase of streptolysin O toxicity in the whole heart is a gradual loss of force of contraction. This defect apparently does not result from damage to the myocardial contractile mechanism itself but to the system which distributes the excitatory impulses. That the contractile mechanism is functional was established by the ability of isolated strips of myoeardium from arrested ventricles of insulted hearts to contract normally when artificially stimulated. In addition, high concentrations of streptolysin O had no toxic effects on isolated ventricle strips from normal hearts. This is in conformance with the findings of Goullet et ah (21) who observed only a transient, positive inotropic effect in the isolated ventricle strip of the rat. The observation that, at ventricular standstill, the atria beat normally indicates that the sinoatrial node is functional. These findings suggest that the ventricular arrest results not from damage to the contractile tissue of the ventricles, but to the atrioventricular node or to other components of the conduction system. This conclusion substantiates the in vivo findings of Halbert et al. (4) and Halpern et al. (3) whose electrocardiographic data showed conduction defects and ventricular automatism.
It is evident that acetylcholine plays no part in the ventricular depression of the irreversible terminal phase. The studies on the isolated intact heart demonstrated (a) that atropine and eserine had no effects on the ultimate decline of ventricular force of contraction, and (b) that hearts challenged with large doses of acetylcholine recovered fully from cardiac arrest and failed to show any of the long term effects characteristic of the terminal phase produced by streptolysin O. Additionally, isolated ventricle strips from normal hearts show no electrophysiological or mechanical changes subsequent to huge doses of streptolysin O or acetylcholine. This is in conformance with previous work which established the lack of parasympathetic innervation of the ventricles and their insensitivity to acetylcholine (22) .
The analysis of the cardiac response to larger doses of toxin is complicated by the immediate and permanent cessation of coronary perfusion. Fig. 2 (dashed line) shows the decrease in contraction amplitude resulting from artificially blocking coronary perfusion. This was also shown by Kellner et al. (2) who stopped coronary flow and noted a rapid decrease in ventricular contractile force which, however, recovered completely after restoration of normal perfusion. Thus, at high levels of streptolysin O intoxication, it is not possible to distinguish between the deleterious effects of anoxia and the decreased ventricular activity owing to the action of the toxin on impulse conduction. Such a distinction, however, is possible with lower amounts of toxin which invariably lead to an irreversible decrease in ventricular function, though they produce only transient lowering of perfusion.
Contrary to the experience with intact animals (5), our work failed to produce any evidence that serotonin plays an active role in the in vitro cardiotoxicity of streptolysin O. On the contrary, the changes produced by the extremely large doses of the amine, i.e., (a) positive inotropic and chronotropic effect on atria, (b) positive inotropic action on the driven ventricle strip, and (c) increased coronary flow in the whole heart, are opposite to the changes produced by the toxin. Furthermore, serotonin antagonists appeared to have no effect against the actions of streptolysin O in the isolated atria or whole heart.
It is interesting to consider the results of these studies and those of Halbert et al. (4) in relation to certain of the clinical manifestations of streptococcal infections and their sequelae in man. The electrocardiograms of patients suffering from scarlet fever, streptococcal pharyngitis, and rheumatic fever often show abnormalities characteristic of damage to the atrioventricular node or ventricular conduction system. The most common change is prolongation of the P-R interval, but partial atrioventricular heart block, atrioventricular dissociation, inversion of the T wave, and bundle branch block are also encountered (23, 24) . These observations are of interest in light of Halhert's in vivo electrocardiographic findings of conduction defects following injection of streptolysin O into rabbits, and our own evidence that the in vitro toxicity of streptolysin O for the guinea pig heart results from damage to the conduction system. If the toxin is present during the course of rheumatic fever, as suggested by the high anti-streptolysin O titers in patients suffering from the disease (25) , the present findings are in accord with the concept that this molecule may be responsible for the conduction defects represented by the diagnostic abnormalities of the electrocardiogram.
SIYM~RY
The response of isolated guinea pig hearts to perfusion with purified streptolysin O is characterized by a rapid, but transient, decrease in rate and amplitude of contraction; these reactions are superimposed upon a gradual, irreversible, loss of ventricular contractility. At ventricular standstill, the atria continue to beat spontaneously in a normal way. Isolated ventricle strips prepared from such preparations can be driven electrically, and their behavior is functionally indistinguishable from that of similar preparations made from normal hearts.
Tests on spontaneously beating isolated atrial pairs show that the toxin induces a dose-dependent, reversible, decline in rate and amplitude which is accompanied by a marked, but transient, increase in the velocity of repolarization of the intracellular potential. The atrial reactions were completely blocked by atropine and potentiated by eserine.
Acetylcholine was detected in the perfusates obtained by incubating a large pool of atrial tissue with active toxin, supporting the inference that the transient mechanical and electrophysiological reactions to toxin might be consequences of the release of acetylcholine from these tissues by the active toxin.
Control studies showed that only the active toxin had the capacity to induce the cardiac responses. The toxin was active only in the reduced but not the oxidized form. The effects of the active toxin were modified if it were heated prior to challenge, and they could be neutralized by specific antiserum and inhibited by cholesterol.
Since the driven ventricle strip was mechanically and electrophysiologically insensitive to streptolysin O, the irreversible changes in the whole heart must have occurred because of a defect in the atrioventricular conduction system.
